Skip to main content
Tofacitinib shows mortality benefit in patients with COVID-19 pneumonia
Primary tabs
•••
View
Get Stamp Tags
Published Locations
Breadcrumb
Home
Tofacitinib shows mortality benefit in patients with COVID-19 pneumonia
User login
Username
Password
Reset your password
Specialty
Lead
score
Rheumatology
1
1
Family Medicine/Primary Care
0
0.8
Infectious Diseases
0
0.85
Pulmonary Medicine
0
0.95
Hospital Medicine
0
0.9
Concept
Lead
score
COVID-19
1
0.93
Hospital
0
0.71
Respiratory Failure
0
0.41
Pneumonia
0
0.9
Acute Myocardial Infarction (MI)
0
0.14
Cardiogenic Shock
0
0.14
Ventricular Tachycardia
0
0.14
Cerebrovascular Accident
0
0.13
Thromboembolism
0
0.13
Allergy
0
0.1
Arthritis
0
0.1
Glucocorticoid
0
0.1
Grant
0
0.1
Hemorrhagic Stroke
0
0.1
Infarction
0
0.1
Intensive Care Unit
0
0.1
Myocarditis
0
0.1
Receptors
0
0.1
Shock
0
0.1
Tachycardia
0
0.1
Thrombosis
0
0.1
Vein
0
0.1
Arrhythmia
0
0.09
Myocardial Infarction (MI)
0
0.09
Deep Venous Thrombosis
0
0.08
Rheumatoid Arthritis
0
0.08
Cardiomyopathy
0
0.05